# Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

> **NCT00932581** · — · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** Bradykinesia UPDRS Motor Full Examination
- **OTHER:** Bradykinesia subscale of UPDRS Motor Examination

## Key facts

- **NCT ID:** NCT00932581
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00932581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00932581, "Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00932581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*